Silence Therapeutics (SLN) EBT Margin (2024 - 2026)
Silence Therapeutics (SLN) reported EBT Margin of 3544.31% for Q1 2026, up 1654724.0% on a YoY basis from N/an in Q1 2025, and up 89.76% sequentially from 34617.65% in Q4 2025.
Silence Therapeutics (SLN) EBT Margin (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of EBT Margin data on file, last reported at 3544.31% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 1654724.0% year-over-year to 3544.31%; the trailing twelve-month figure through Mar 2026 stood at 8942.55% (down 868692.0% YoY), and the FY2025 full-year result was 15849.91%, down 1574712.0% from the prior year.
- EBT Margin rose to 3544.31% in Q1 2026, from 34617.65% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 49.9% in Q4 2024 to a low of 34617.65% in Q4 2025.
- A 3-year average of 9823.87% and a median of 3544.31% in 2026 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin plunged 3466754 bps in 2025 and jumped 1654724 bps in 2026, its largest moves.
- Tracing SLN's EBT Margin over 3 years: stood at 49.9% in 2024, then sank by 69481 bps to 34617.65% in 2025, then soared by 90 bps to 3544.31% in 2026.
- Business Quant data shows SLN's EBT Margin at 3544.31% in Q1 2026, 34617.65% in Q4 2025, and 13180.5% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | -3,544.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,544.31% |
| Dec 31, 2025 | -34,617.65% |
| Sep 30, 2025 | -13,180.50% |
| Jun 30, 2025 | -12,207.14% |
| Mar 31, 2025 | -20,091.55% |
| Dec 31, 2024 | 49.90% |
| Sep 30, 2024 | -2,369.49% |
| Jun 30, 2024 | -2,440.88% |
| Mar 31, 2024 | -13.17% |